8.4134

2.47% 0.2034

Adma Biologics Inc (ADMA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$8.21

Offen:

$8.26

24-Stunden-Volumen:

886.19K

Relative Volume:

0.13

Marktkapitalisierung:

$1.95B

Einnahmen:

$509.86M

Nettoeinkommen (Verlust:

$165.35M

KGV:

12.41

EPS:

0.6779

Netto-Cashflow:

$107.55M

1W Leistung:

+4.38%

1M Leistung:

+1.73%

6M Leistung:

-57.36%

1J Leistung:

-59.57%

1-Tages-Spanne:

$8.23

$8.51

1-Wochen-Bereich:

$8.02

$8.895

52-Wochen-Spanne:

$7.2101

$20.97

Adma Biologics Inc Stock (ADMA) Company Profile

Firmenname

Adma Biologics Inc

Sektor

Healthcare (1112)

Branche

Biotechnology (621)

Telefon

(201) 478-5552

Adresse

C/O ADMA BIOLOGICS, INC., RAMSEY

Mitarbeiter

647

Twitter

@AdmaBiologics

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

ADMA's Discussions on Twitter

Compare ADMA vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ADMA Adma Biologics Inc	8.415	1.90B	509.86M	165.35M	107.55M	0.6779
VRTX Vertex Pharmaceuticals Inc	450.31	112.92B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	613.56	64.18B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	880.79	55.57B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	286.28	37.76B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	159.06	32.71B	742.00K	-1.37B	-1.07B	-7.0731

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-21	Eingeleitet	Canaccord Genuity	Buy
2026-03-26	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2023-07-19	Fortgesetzt	Raymond James	Strong Buy
2022-10-13	Eingeleitet	Mizuho	Buy
2021-11-11	Hochstufung	Raymond James	Outperform → Strong Buy
2021-11-09	Eingeleitet	Cantor Fitzgerald	Overweight
2019-06-04	Eingeleitet	Jefferies	Buy
2019-04-15	Bestätigt	H.C. Wainwright	Buy
2019-02-07	Fortgesetzt	H.C. Wainwright	Buy
2017-12-11	Bestätigt	Maxim Group	Buy
2017-11-14	Hochstufung	Raymond James	Mkt Perform → Outperform
2017-01-23	Hochstufung	Maxim Group	Hold → Buy
2016-08-01	Herabstufung	Maxim Group	Buy → Hold
2016-07-25	Bestätigt	Maxim Group	Buy
2015-05-13	Bestätigt	Maxim Group	Buy
2014-12-08	Eingeleitet	Oppenheimer	Outperform
2014-12-01	Bestätigt	Maxim Group	Buy

Alle ansehen

Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten

07:06 AM

ADMA Biologics Fair Value call saved investors from 40% decline By Investing.com - Investing.com Canada

07:06 AM

Jun 14, 2026

ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Jun 14, 2026

Jun 13, 2026

Lost Money on ADMA Biologics, Inc. (ADMA)? Join Class Action Before August 10, 2026Contact Levi & Korsinsky - ACCESS Newswire

Jun 13, 2026

Nomura VIP Small Cap Growth Series's ADMA Biologics Inc(ADMA) Holding History - GuruFocus

Jun 13, 2026

Jun 12, 2026

ADMA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

Jun 12, 2026

ADMA INVESTOR ALERT: ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead the ADMA Biologics Class Action Lawsuit - The Malaysian Reserve

Jun 12, 2026

ADMA Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against ADMA Biologics, Inc. - PR Newswire

Jun 12, 2026

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - StreetInsider

Jun 12, 2026

ADMA Biologics Faces Securities Fraud Lawsuit - Intellectia AI

Jun 12, 2026

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages ADMA Biologics, Inc. (ADMA) Shareholders To Inquire About Securities Fraud Class Action - Benzinga

Jun 12, 2026

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, - GlobeNewswire

Jun 12, 2026

DEADLINE ALERT for VIA, Z, and ADMA: The Law Offices of - GlobeNewswire

Jun 12, 2026

Law Offices of Frank R. Cruz Encourages ADMA Biologics, Inc. (ADMA) Shareholders To Inquire About Securities Fraud Class Action - Business Wire

Jun 12, 2026

$ADMA Class Action Alert: ADMA Biologics Channel Stuffing - GlobeNewswire

Jun 12, 2026

$ADMA Lawsuit: ADMA Biologics Channel Stuffing Allegations Trigger Securities Fraud Class ActionInvestors Notified of August 10 Court Deadline - ACCESS Newswire

Jun 12, 2026

Jun 11, 2026

ADMA Stock Downgraded By Cantor As ‘Channel Stuffing’ Claims Shake Investor Confidence - Stocktwits

Jun 11, 2026

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - lincolnjournal.com

Jun 11, 2026

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - PR Newswire

Jun 11, 2026

INVESTOR ALERT: Securities Class Action Filed Against ADMA Biologics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP - mydailyrecord.com

Jun 11, 2026

ADMA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - Bluefield Daily Telegraph

Jun 11, 2026

Law Offices of Howard G. Smith Encourages ADMA Biologics, Inc. (ADMA) Shareholders To Inquire About Securities Fraud Class Action - lincolnjournal.com

Jun 11, 2026

$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop – Investors Notified to Contact BFA Law - The Malone Telegram

Jun 11, 2026

ADMA INVESTOR ALERT: Class Action Lawsuit Filed on Behalf - GlobeNewswire

Jun 11, 2026

Jun 10, 2026

Investor Notice: Robbins LLP Informs Investors of the ADMA Biologics, Inc. Class Action Lawsuit - Business Wire

Jun 10, 2026

Class Action Lawsuit Filed Against ADMA Biologics - Intellectia AI

Jun 10, 2026

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel ... - Caledonian Record

Jun 10, 2026

ADMA LAWSUIT: ADMA Biologics, Inc. Sued For Securities Fraud; Investors Should Contact Block ... - Caledonian Record

Jun 10, 2026

ADMA LAWSUIT: ADMA Biologics, Inc. Sued For Securities - GlobeNewswire

Jun 10, 2026

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of ADMA Biologics, Inc. Investors – ADMA - The Joplin Globe

Jun 10, 2026

Raymond James Initiates ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $21 - Moomoo

Jun 10, 2026

ADMA: Analyst Upgrades Stock with $21 Price Target - GuruFocus

Jun 10, 2026

Raymond James initiates ADMA Biologics stock coverage with outperform rating - Investing.com Nigeria

Jun 10, 2026

ADMA Biologics Investigation: ADMA Biologics (ADMA) - GlobeNewswire

Jun 10, 2026

Jun 08, 2026

(ADMA) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Jun 08, 2026